• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    LIFESTANCE HEALTH NAMES DANISH QURESHI AS CHIEF OPERATING OFFICER, EFFECTIVE JULY 1, 2022

    5/23/22 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care
    Get the next $LFST alert in real time by email

    Gwen Booth Retiring from COO Role; Appointed as Executive Director, LifeStance Health Foundation

    SCOTTSDALE, Ariz., May 23, 2022 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that its Board of Directors approved the appointment of Danish Qureshi, currently Chief Growth Officer, LifeStance, as the company's next Chief Operating Officer, effective July 1, 2022. Gwen Booth, who has served as COO since the company's founding in 2017, is retiring from her operating role and will become the first Executive Director of LifeStance Health Foundation (the "Foundation"). Established in 2021, the Foundation is a 501(c)(3) non-profit organization that was endowed to award grants, make scholarships and support organizations that share LifeStance's vision to improve mental health access.

    LifeStance Health Logo (PRNewsfoto/LifeStance Health)

    "As a highly-experienced healthcare executive and founding member of the LifeStance team, Danish is well-positioned to successfully guide our business through its next phase of growth," said Michael Lester, Chairman and CEO, LifeStance. "Danish has been instrumental in the success of our organic growth engine and the rapid scaling of our business since inception. He has an excellent track record delivering against our long-term strategic priorities, and we are confident that he will excel in this new role."

    "I'm excited to step into this new role and build on the strong foundation developed by Gwen and our entire operations team," said Qureshi. "There has never been a more important time to increase access to trusted, affordable and personalized mental healthcare. We are committed to delivering positive outcomes for our patients, employees and shareholders, and in doing so, make significant progress toward our vision of a truly healthy society where mental and physical healthcare are unified to make lives better. Gwen has been a trusted partner since the founding of the company, and I look forward to working closely together during this transition."

    "On behalf of our executive leadership team and all our teams across the country, we are grateful for Gwen's contributions during her tenure. We're delighted that she will continue to support LifeStance's commitment to reimagining mental health through the Foundation," added Lester. 

    "I'm extremely proud of LifeStance's success and what we've achieved to make high-quality mental healthcare widely available across the country," said Booth. "I'm grateful to every single LifeStance team member who has contributed to advancing our mission, and I look forward to combining my passion for enhancing access to care with non-profit work by leading the Foundation."

    ABOUT DANISH QURESHI

    In his current role as Chief Growth Officer, Qureshi oversees all organic growth initiatives for the company. He leads clinician recruiting, de novo center openings, payor contracting, customer care and national marketing. Previously, Qureshi was the SVP of Strategic Initiatives at Accelecare Wound Centers, Inc. and COO of the post-acute division, Accelecare Wound Professionals, LLC. While at Accelecare, he grew the post-acute division into a nationwide network of 400 skilled nursing facilities under contract, with physicians employed across 22 states. Prior to Accelecare, Qureshi worked at Nautic Partners, a mid-market private equity firm, with a sector focus on healthcare. He began his career as a management consultant with Bain & Company. Qureshi received his B.A. from Northwestern University.

    ABOUT LIFESTANCE HEALTH

    Founded in 2017, LifeStance (NASDAQ:LFST) is reimagining mental health. We are one of the nation's largest providers of virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental healthcare. LifeStance employs approximately 5,000 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 32 states and more than 500 centers. To learn more, please visit www.LifeStance.com. 

    ABOUT LIFESTANCE HEALTH FOUNDATION

    Established in 2021, LifeStance Health Foundation is a 501(c)(3) non-profit organization that was endowed to award grants, make scholarships and support organizations that share LifeStance's vision to improve mental health access. The Foundation focuses on especially vulnerable patients including youth and adolescents, underrepresented minority communities and the underemployed and uninsured. To date, the Foundation has awarded more than $400,000 to both national and local non-profits working to destigmatize access to mental healthcare. 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lifestance-health-names-danish-qureshi-as-chief-operating-officer-effective-july-1-2022-301552485.html

    SOURCE LifeStance Health

    Get the next $LFST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LFST

    DatePrice TargetRatingAnalyst
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    4/3/2025$8.00Buy
    Canaccord Genuity
    12/16/2024$10.00Neutral → Buy
    Goldman
    1/3/2024$7.00Underweight
    Barclays
    5/15/2023$8.00 → $9.00Outperform → Market Perform
    TD Cowen
    1/6/2023$8.00Equal-Weight → Overweight
    Morgan Stanley
    11/7/2022$7.25Buy
    Jefferies
    3/17/2022$19.00 → $10.00Buy → Neutral
    UBS
    More analyst ratings

    $LFST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Pardo Ryan covered exercise/tax liability with 12,280 shares, decreasing direct ownership by 1% to 915,735 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:52:55 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Director Burdick Kenneth A covered exercise/tax liability with 35,817 shares, decreasing direct ownership by 1% to 3,368,901 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:50:35 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Bourdon David covered exercise/tax liability with 10,884 shares, decreasing direct ownership by 1% to 888,239 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:50:06 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Leadership Updates

    Live Leadership Updates

    See more
    • LifeStance Names Vaughn Paunovich as Chief Technology Officer

      SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

      5/14/25 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • LifeStance Appoints Dr. Teresa DeLuca to Board of Directors

      SCOTTSDALE, Ariz., March 12, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of directors. "Dr. DeLuca's background

      3/12/24 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/14/24 4:34:15 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/14/24 9:59:56 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/8/24 4:33:25 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $LFST
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $LFST
    SEC Filings

    See more
    • KeyBanc Capital Markets initiated coverage on LifeStance Health Group with a new price target

      KeyBanc Capital Markets initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $9.00

      4/8/25 9:29:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Canaccord Genuity initiated coverage on LifeStance Health Group with a new price target

      Canaccord Genuity initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00

      4/3/25 8:18:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Health Group upgraded by Goldman with a new price target

      Goldman upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $10.00

      12/16/24 6:31:31 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Names Vaughn Paunovich as Chief Technology Officer

      SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

      5/14/25 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

      SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 6060781, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor R

      4/21/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Health Group Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/14/25 9:34:10 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by LifeStance Health Group Inc.

      10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/7/25 4:42:46 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by LifeStance Health Group Inc.

      DEFA14A - LifeStance Health Group, Inc. (0001845257) (Filer)

      4/23/25 4:54:39 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Financials

    Live finance-specific insights

    See more
    • LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

      SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 6060781, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor R

      4/21/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman

      Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz., Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer. Bourdon, who joined LifeStance as Chief Financial Officer in 2022, is succeeding Ken Burdick, who is retiring from his role as CEO and will assume the role of Executive Chairman. Bourdon has also been appointed to serve on the Board of Directors. In addition, Ryan McGroarty has been appointed to serve as the company's new Chief Financ

      2/27/25 6:02:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025

      SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 27, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 4372752, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentati

      2/6/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care